Drug Database
C09DA04 irbesartan and diuretics
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM CoAprovel 150mg/12.5mg Tablets
- POM CoAprovel 300mg/12.5mg Tablets
- POM Irbesartan and Hydrochlorothiazide Milpharm 150 mg/ 12.5 mg film-coated tablets
- POM Irbesartan and Hydrochlorothiazide Milpharm 300 mg/ 12.5 mg film-coated tablets
- POM Irbesartan and Hydrochlorothiazide Milpharm 300 mg/ 25 mg film-coated tablets
- POM Irbesartan Hydrochlorothiazide 150mg/12.5mg Film-coated Tablets
- POM Irbesartan Hydrochlorothiazide 300mg/12.5mg Film-coated Tablets
- POM Irbesartan Hydrochlorothiazide 300mg/25mg Film-coated Tablets
- POM Irbesartan/Hydrochlorothiazide Brown & Burk 150 mg/12.5 mg Film-coated tablets
- POM Irbesartan/Hydrochlorothiazide Brown & Burk 300 mg/12.5 mg Film-coated tablets
- POM Irbesartan/Hydrochlorothiazide Brown & Burk 300 mg/25 mg Film-coated tablets
- POM Irbesartan/Hydrochlorothiazide Mylan 150 mg/12.5 mg Tablets
- POM Irbesartan/Hydrochlorothiazide Mylan 300 mg/12.5 mg Tablets
- POM Irbesartan/Hydrochlorothiazide Mylan 300 mg/25 mg Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).